Publications by authors named "Eva Calvo-Pinilla"

Claim this Profile
N
Neutral sphingomyelinase 2 inhibition alters inflammatory gene expression signatures in the brain of mice infected with West Nile virus.
Patricia Mingo-Casas, Hadrián Álvarez-Fernández, Ana-Belén Blázquez, Ana Esteban, Estela Escribano-Romero, Eva Calvo-Pinilla

Int Immunopharmacol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rapid Quantification of Bluetongue Virus-Neutralizing Antibodies Using Bioluminescent Reporter-Expressing Viruses.
Luis Jiménez-Cabello, Sergio Utrilla-Trigo, Eva Calvo-Pinilla, Aitor Nogales, Javier Ortego

Vaccines (Basel)· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The 40Fp8 vaccine strain is safe and protects pregnant ewes from a virulent RVFV challenge.
Belén Borrego, Celia Alonso, Sandra Moreno, Eva Calvo-Pinilla, Gema Lorenzo

NPJ Vaccines· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The MVA-VP2-NS1-2A-NS2-Nt vaccine candidate provides heterologous protection in sheep against bluetongue virus.
Luis Jiménez-Cabello, Sergio Utrilla-Trigo, Miguel Illescas-Amo, Karen Rodríguez-Sabando, Julio Benavides-Silván, Eva Calvo-Pinilla

Front Immunol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthetic heparan sulfate mimics based on chitosan derivatives show broad-spectrum antiviral activity.
Julia Revuelta, Luciana Rusu, Clara Frances-Gomez, Elena Trapero, Susana Iglesias

Commun Biol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prime-Boost Vaccination Based on Nanospheres and MVA Encoding the Nucleoprotein of Crimean-Congo Hemorrhagic Fever Virus Elicits Broad Immune Responses.
Eva Calvo-Pinilla, Sandra Moreno, Natalia Barreiro-Piñeiro, Juana M Sánchez-Puig, Rafael Blasco

Vaccines (Basel)· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vaccine candidates based on MVA viral vectors expressing VP2 or VP7 confer full protection against Epizootic hemorrhagic disease virus in IFNAR(-/-) mice.
Luis Jiménez-Cabello, Sergio Utrilla-Trigo, Karen Rodríguez-Sabando, Alejandro Carra-Valenzuela, Miguel Illescas-Amo, Eva Calvo-Pinilla

J Virol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Co-expression of VP2, NS1 and NS2-Nt proteins by an MVA viral vector induces complete protection against bluetongue virus.
Luis Jiménez-Cabello, Sergio Utrilla-Trigo, Eva Calvo-Pinilla, Gema Lorenzo, Miguel Illescas-Amo

Front Immunol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Susceptibility and transmissibility of SARS-CoV-2 variants in transgenic mice expressing the cat angiotensin-converting enzyme 2 (ACE-2) receptor.
Nereida Jiménez de Oya, Eva Calvo-Pinilla, Patricia Mingo-Casas, Estela Escribano-Romero, Ana-Belén Blázquez

One Health· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IFNAR(-/-) Mice Constitute a Suitable Animal Model for Epizootic Hemorrhagic Disease Virus Study and Vaccine Evaluation.
Luis Jiménez-Cabello, Sergio Utrilla-Trigo, Julio Benavides-Silván, Juan Anguita, Eva Calvo-Pinilla

Int J Biol Sci· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Engineering recombinant replication-competent bluetongue viruses expressing reporter genes for and non-invasive studies.
Sergio Utrilla-Trigo, Luis Jiménez-Cabello, Alejandro Marín-López, Miguel Illescas-Amo, Germán Andrés, Eva Calvo-Pinilla

Microbiol Spectr· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cytokine mRNA Expression Profile in Target Organs of IFNAR (-/-) Mice Infected with African Horse Sickness Virus.
Eva Calvo-Pinilla, Luis Jiménez-Cabello, Sergio Utrilla-Trigo, Miguel Illescas-Amo, Javier Ortego

Int J Mol Sci· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Glycolytic shift during West Nile virus infection provides new therapeutic opportunities.
Patricia Mingo-Casas, Ana-Belén Blázquez, Marta Gómez de Cedrón, Ana San-Félix, Susana Molina, Eva Calvo-Pinilla

J Neuroinflammation· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vaccinia Virus Strain MVA Expressing a Prefusion-Stabilized SARS-CoV-2 Spike Glycoprotein Induces Robust Protection and Prevents Brain Infection in Mouse and Hamster Models.
María M Lorenzo, Alejandro Marín-López, Kevin Chiem, Luis Jimenez-Cabello, Irfan Ullah, Eva Calvo-Pinilla

Vaccines (Basel)· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epizootic Hemorrhagic Disease Virus: Current Knowledge and Emerging Perspectives.
Luis Jiménez-Cabello, Sergio Utrilla-Trigo, Gema Lorenzo, Javier Ortego, Eva Calvo-Pinilla

Microorganisms· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacological Elevation of Cellular Dihydrosphingomyelin Provides a Novel Antiviral Strategy against West Nile Virus Infection.
Nereida Jiménez de Oya, Ana San-Félix, Mireia Casasampere, Ana-Belén Blázquez, Patricia Mingo-Casas, Eva Calvo-Pinilla

Antimicrob Agents Chemother· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Non-coding RNAs derived from the foot-and-mouth disease virus genome trigger broad antiviral activity against coronaviruses.
Miguel Rodríguez-Pulido, Eva Calvo-Pinilla, Miryam Polo, Juan-Carlos Saiz, Raúl Fernández-González

Front Immunol· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Combined Expression of the Nonstructural Protein NS1 and the N-Terminal Half of NS2 (NS2) by ChAdOx1 and MVA Confers Protection against Clinical Disease in Sheep upon Bluetongue Virus Challenge.
Sergio Utrilla-Trigo, Luis Jiménez-Cabello, Eva Calvo-Pinilla, Alejandro Marín-López, Gema Lorenzo

J Virol· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recombinant Rift Valley fever viruses encoding bluetongue virus (BTV) antigens: Immunity and efficacy studies upon a BTV-4 challenge.
Sandra Moreno, Eva Calvo-Pinilla, Stephanie Devignot, Friedemann Weber, Javier Ortego

PLoS Negl Trop Dis· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Viral Vector Vaccines against Bluetongue Virus.
Luis Jiménez-Cabello, Sergio Utrilla-Trigo, Eva Calvo-Pinilla, Sandra Moreno, Aitor Nogales

Microorganisms· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reverse genetics approaches: a novel strategy for African horse sickness virus vaccine design.
Eva Calvo-Pinilla, Alejandro Marín-López, Sergio Utrilla-Trigo, Luís Jiménez-Cabello, Javier Ortego

Curr Opin Virol· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of Orbivirus Replication by Aurintricarboxylic Acid.
Celia Alonso, Sergio Utrilla-Trigo, Eva Calvo-Pinilla, Luis Jiménez-Cabello, Javier Ortego

Int J Mol Sci· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A protective bivalent vaccine against Rift Valley fever and bluetongue.
Eva Calvo-Pinilla, Alejandro Marín-López, Sandra Moreno, Gema Lorenzo, Sergio Utrilla-Trigo

NPJ Vaccines· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Heterologous Combination of ChAdOx1 and MVA Vectors Expressing Protein NS1 as Vaccination Strategy to Induce Durable and Cross-Protective CD8+ T Cell Immunity to Bluetongue Virus.
Sergio Utrilla-Trigo, Luis Jiménez-Cabello, Ruymán Alonso-Ravelo, Eva Calvo-Pinilla, Alejandro Marín-López

Vaccines (Basel)· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cross-protective immune responses against African horse sickness virus after vaccination with protein NS1 delivered by avian reovirus muNS microspheres and modified vaccinia virus Ankara.
Alejandro Marín-López, Natalia Barreiro-Piñeiro, Sergio Utrilla-Trigo, Diego Barriales, Javier Benavente, Eva Calvo-Pinilla

Vaccine· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis